NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.800
-0.040 (-2.17%)
At close: Aug 1, 2025, 4:00 PM
1.899
+0.099 (5.49%)
After-hours: Aug 1, 2025, 7:19 PM EDT

Aspen Technology Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Aspen Technology.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Aspen Technology.

Recommendation Trends

RatingApr '23May '23Jun '23Jul '23Aug '23Sep '23
Strong Buy222220
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222220

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aSep 14, 2023
Maxim Group
Maxim Group
Strong Buy
Upgrades
$160
Strong BuyUpgrades$160+8,788.89%Dec 8, 2022
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aNov 8, 2022
Laidlaw & Co.
Laidlaw & Co.
Strong Buy
Initiates
$240
Strong BuyInitiates$240+13,233.33%Sep 6, 2022
Brookline Capital
Brookline Capital
Strong Buy
Initiates
$480
Strong BuyInitiates$480+26,566.67%Mar 12, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.46
from -2.63
EPS Next Year
n/a
from -0.46
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue
------
Revenue Growth
------
EPS
-16.45-40.15-33.52-12.75-2.63-0.46
EPS Growth
------
Forward PE
------
No. Analysts
-----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth2025
High-
Avg-
Low-

EPS Forecast

EPS2025
High-0.47
Avg-0.46
Low-0.44

EPS Growth

EPS Growth2025
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.